News

Yahoo Finance16d
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology - Yahoo Finance
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technologyResearch builds on ...
Eagle-Tribune16d
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation ... - Eagle-Tribune
ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...
EurekAlert!16d
Emory University and Micron Biomedical launch first-in-human clinical trial of next-generation rotavirus vaccine delivered via dissolvable microarray technology - EurekAlert!
Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...